Carl Zeiss Meditec AG Stock Berne S.E.
Equities
AFX
DE0005313704
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
104.7 CHF | -10.65% | -10.65% | +12.25% |
May. 31 | Carl Zeiss Meditec just above annual low - JPMorgan skeptical | DP |
May. 31 | JPMorgan puts Carl Zeiss Meditec on 'Negative Catalyst Watch' | DP |
Sales 2024 * | 2.23B 2.43B 2.16B | Sales 2025 * | 2.51B 2.73B 2.43B | Capitalization | 7.51B 8.17B 7.28B |
---|---|---|---|---|---|
Net income 2024 * | 255M 277M 247M | Net income 2025 * | 312M 339M 302M | EV / Sales 2024 * | 3.55 x |
Net Debt 2024 * | 396M 431M 384M | Net Debt 2025 * | 345M 375M 335M | EV / Sales 2025 * | 3.13 x |
P/E ratio 2024 * |
29.5
x | P/E ratio 2025 * |
23.8
x | Employees | - |
Yield 2024 * |
1.26% | Yield 2025 * |
1.42% | Free-Float | 40.86% |
Latest transcript on Carl Zeiss Meditec AG
1 day | -10.65% |
Managers | Title | Age | Since |
---|---|---|---|
Markus Weber
CEO | Chief Executive Officer | 51 | 21-12-30 |
Director of Finance/CFO | 59 | 18-09-30 | |
Christian Müller
BRD | Director/Board Member | 57 | 09-12-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Kaschke
BRD | Director/Board Member | 67 | 01-12-31 |
Peter Kameritsch
BRD | Director/Board Member | 55 | 21-05-26 |
Heike Madan
BRD | Director/Board Member | 52 | 23-03-21 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.32% | 217B | |
+13.83% | 195B | |
+20.48% | 144B | |
+31.33% | 112B | |
+3.08% | 65.83B | |
+14.64% | 52.67B | |
+2.72% | 49.86B | |
-5.88% | 38.18B | |
+0.25% | 35.39B |
- Stock Market
- Equities
- AFX Stock
- AFX Stock